TD Cowen lowered the firm’s price target on Acadia Healthcare (ACHC) to $44 from $66 and keeps a Buy rating on the shares. The firm updated its model following Q4 results while noting the 2025 EBITDA guidance assumes incremental professional fees, closure/startup losses and no material improvement in underperforming facilities.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $37 from $48 at Mizuho
- Acadia Healthcare price target lowered to $43 from $64 at RBC Capital
- Acadia Healthcare price target lowered to $65 from $70 at KeyBanc
- Strategic Growth Amidst Challenges: Whit Mayo’s Buy Rating on Acadia Healthcare
- Acadia Healthcare price target lowered to $40 from $44.50 at BofA